ExCellThera Announces Positive Phase 2 Study Results from UM

ExCellThera Announces Positive Phase 2 Study Results from UM171 Cell Therapy in Patients with High-risk Leukemias and Myelodysplasias at American Society of Hematology (ASH) 2023 Annual Meeting

ExCellThera Announces Positive Phase 2 Study Results from UM171 Cell Therapy in Patients with High-risk Leukemias and Myelodysplasias at American Society of Hematology (ASH) 2023 Annual Meeting

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Milano , Lombardia , Italy , Montreal , Quebec , Canada , United States , American , Sarah Ellinwood , David Millette , Linkedin , American Society Of Hematology Annual Meeting Exposition , Excellthera Inc , American Society Of Hematology , Fred Hutch Cord Blood Transplant Program , Fred Hutchinson Cancer Center , Health Canada , Therapeutics Division , Cellthera Announces Positive Phase , High Risk Leukemias , American Society , Hematology Annual Meeting , Filippo Milano , Associate Professor , Translational Science , Fred Hutch , Cord Blood Transplant , Chief Executive Officer , Media Contact , Kendall Investor Relations ,